IBDEI24J ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36021,2)
 ;;=^269949
 ;;^UTILITY(U,$J,358.3,36022,0)
 ;;=J45.998^^134^1740^2
 ;;^UTILITY(U,$J,358.3,36022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36022,1,3,0)
 ;;=3^Asthma NEC
 ;;^UTILITY(U,$J,358.3,36022,1,4,0)
 ;;=4^J45.998
 ;;^UTILITY(U,$J,358.3,36022,2)
 ;;=^5008257
 ;;^UTILITY(U,$J,358.3,36023,0)
 ;;=J43.8^^134^1740^15
 ;;^UTILITY(U,$J,358.3,36023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36023,1,3,0)
 ;;=3^Emphysema NEC
 ;;^UTILITY(U,$J,358.3,36023,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,36023,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,36024,0)
 ;;=J43.1^^134^1740^28
 ;;^UTILITY(U,$J,358.3,36024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36024,1,3,0)
 ;;=3^Panlobular Emphysema
 ;;^UTILITY(U,$J,358.3,36024,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,36024,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,36025,0)
 ;;=J45.51^^134^1740^29
 ;;^UTILITY(U,$J,358.3,36025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36025,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,36025,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,36025,2)
 ;;=^5008252
 ;;^UTILITY(U,$J,358.3,36026,0)
 ;;=J45.52^^134^1740^30
 ;;^UTILITY(U,$J,358.3,36026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36026,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,36026,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,36026,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,36027,0)
 ;;=J45.50^^134^1740^31
 ;;^UTILITY(U,$J,358.3,36027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36027,1,3,0)
 ;;=3^Severe Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,36027,1,4,0)
 ;;=4^J45.50
 ;;^UTILITY(U,$J,358.3,36027,2)
 ;;=^5008251
 ;;^UTILITY(U,$J,358.3,36028,0)
 ;;=J43.0^^134^1740^32
 ;;^UTILITY(U,$J,358.3,36028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36028,1,3,0)
 ;;=3^Unilateral Pulmonary Emphysema
 ;;^UTILITY(U,$J,358.3,36028,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,36028,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,36029,0)
 ;;=J45.901^^134^1740^3
 ;;^UTILITY(U,$J,358.3,36029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36029,1,3,0)
 ;;=3^Asthma w/ Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,36029,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,36029,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,36030,0)
 ;;=J45.902^^134^1740^4
 ;;^UTILITY(U,$J,358.3,36030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36030,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,36030,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,36030,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,36031,0)
 ;;=J45.909^^134^1740^5
 ;;^UTILITY(U,$J,358.3,36031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36031,1,3,0)
 ;;=3^Asthma,Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,36031,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,36031,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,36032,0)
 ;;=J42.^^134^1740^13
 ;;^UTILITY(U,$J,358.3,36032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36032,1,3,0)
 ;;=3^Chr Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,36032,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,36032,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,36033,0)
 ;;=I95.1^^134^1741^1
 ;;^UTILITY(U,$J,358.3,36033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36033,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,36033,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,36033,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,36034,0)
 ;;=I73.9^^134^1741^2
 ;;^UTILITY(U,$J,358.3,36034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36034,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,36034,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,36034,2)
 ;;=^184182
